BridgeMD
New treatment option for Multiple Sclerosis
Official title Montpellier PROspective Cohort in Relapsing Remitting Multiple Sclerosis Using Imaging and Serologic
ClinicalTrials.gov ID: NCT05962177
What this study is testing
- What it's testing
- Several prospective monocentric cohorts of between 250 and 1000 patients have been set up in order to characterize more precisely the evolution of the disease. Nevertheless, due to an initial recruitment carried out in the years 2000-2010, they do not constitute a faithful representation of the patients followed in clinical routine, in particular in terms of distribution of treatments.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 59
You may be able to join if
- Patients over 18 and under 60 years of age
- Patients with Relapsing-remitting MS without relapse for at least 6 months
- EDSS\<6 at time of inclusion
You likely can't join if
- Secondary progressive MS or Primary progressive MS at time of inclusion
- Evidence of disease progression (clinical or radiological)
- Change in treatment within 6 months prior to inclusion
- Subject with a contraindication to MRI (claustrophobia, pacemaker, etc.)
- Inability to follow the follow-up planned by the study
- Pregnant or breastfeeding women
See the full eligibility criteria
- Patients over 18 and under 60 years of age
- Patients with Relapsing-remitting MS without relapse for at least 6 months
- EDSS\<6 at time of inclusion
- Secondary progressive MS or Primary progressive MS at time of inclusion
- Evidence of disease progression (clinical or radiological)
- Change in treatment within 6 months prior to inclusion
- Subject with a contraindication to MRI (claustrophobia, pacemaker, etc.)
- Inability to follow the follow-up planned by the study
- Pregnant or breastfeeding women
- Patient not affiliated to the social security system or not benefiting from such a system
- Adult protected by law or patient under guardianship or curatorship
- Failure to obtain written informed consent after a reflection period
The study team makes the final eligibility decision.
Where it's taking place
- Montpellier, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 59 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Montpellier, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.